Search research articles
Contact Us
Filters
Showing results (441-450 of 2,203) with videos related to
Page
of 221
Sort By:
Journal of Drugs in Dermatology : JDD
|
June 16, 2006
Clobetasol propionate for psoriasis: are ointments really more potent?
Lindsey Warino, Rajesh Balkrishnan, Steven R Feldman
Inquiry : a Journal of Medical Care Organization, Provision and Financing
|
November 11, 1998
Do Medicare HMOs cost shift?
R Feldman, D Wholey, J B Christianson
Southern Medical Journal
|
January 5, 2017
Advances in Psoriasis
Jaclyn Smith, Abigail Cline, Steven R Feldman
Public Understanding of Science (Bristol, England)
|
December 1, 2025
Ethics, generative AI and science communication
Hannah R Feldman, Fabien Medvecky, Michelle Riedlinger
JMIR Dermatology
|
August 26, 2023
Refusal of Retreatment With Topical 5-Fluorouracil Among Patients With Actinic Keratosis: Qualitative Analysis
Rohan Singh, Sarah McCain, Steven R Feldman
The Annals of Pharmacotherapy
|
June 21, 2023
Choosing Systemic Agents for Psoriasis
Christina Kontzias, Rithi Chandy, Steven R Feldman
Community Mental Health Journal
|
November 5, 1999
A model program for the treatment of mentally ill offenders in the community
E Roskes, R Feldman, S Arrington, et al.
The Journal of Dermatological Treatment
|
August 14, 2019
A new spin on improving adherence
Vignesh Ramachandran, Arjun M Bashyam, Steven R Feldman
The Journal of Dermatological Treatment
|
July 7, 2009
Conversations on psoriasis--what patients want and what physicians can provide: a qualitative look at patient and physician expectations
Elizabeth E Uhlenhake, David Kurkowski, Steven R Feldman
Dermatology Online Journal
|
March 9, 2011
Commentary: psoriasis patients with a history of malignancy represent an important but overlooked study population
Paul Persad, Michelle M Levender, Steven R Feldman
Page
of 221
Search research articles
Search
Showing results (441-450 of 2,203) with videos related to
Sort By:
Page
of 221
Journal of Drugs in Dermatology : JDD
|
June 16, 2006
Clobetasol propionate for psoriasis: are ointments really more potent?
Lindsey Warino, Rajesh Balkrishnan, Steven R Feldman
Inquiry : a Journal of Medical Care Organization, Provision and Financing
|
November 11, 1998
Do Medicare HMOs cost shift?
R Feldman, D Wholey, J B Christianson
Southern Medical Journal
|
January 5, 2017
Advances in Psoriasis
Jaclyn Smith, Abigail Cline, Steven R Feldman
Public Understanding of Science (Bristol, England)
|
December 1, 2025
Ethics, generative AI and science communication
Hannah R Feldman, Fabien Medvecky, Michelle Riedlinger
JMIR Dermatology
|
August 26, 2023
Refusal of Retreatment With Topical 5-Fluorouracil Among Patients With Actinic Keratosis: Qualitative Analysis
Rohan Singh, Sarah McCain, Steven R Feldman
The Annals of Pharmacotherapy
|
June 21, 2023
Choosing Systemic Agents for Psoriasis
Christina Kontzias, Rithi Chandy, Steven R Feldman
Community Mental Health Journal
|
November 5, 1999
A model program for the treatment of mentally ill offenders in the community
E Roskes, R Feldman, S Arrington, et al.
The Journal of Dermatological Treatment
|
August 14, 2019
A new spin on improving adherence
Vignesh Ramachandran, Arjun M Bashyam, Steven R Feldman
The Journal of Dermatological Treatment
|
July 7, 2009
Conversations on psoriasis--what patients want and what physicians can provide: a qualitative look at patient and physician expectations
Elizabeth E Uhlenhake, David Kurkowski, Steven R Feldman
Dermatology Online Journal
|
March 9, 2011
Commentary: psoriasis patients with a history of malignancy represent an important but overlooked study population
Paul Persad, Michelle M Levender, Steven R Feldman
Page
of 221